The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Heterogeneity in Lung Cancer
Abstract
Lung cancer diagnosis is a challenge since it is also one of the most frequently diagnosed cancers. Diagnostic challenges are deeply related to the development of personalized therapy and molecular and precise histological characterizations of lung cancer. When addressing these features, it is very important to acknowledge the issue of tumour heterogeneity, as it imposes several questions. First of all, lung cancer is a very heterogeneous disease, at a cellular and histological level. Cellular and histological heterogeneity are addressed with emphasis on the diagnosis, pre-neoplastic lesions, and cell origin, trying to contribute to a better knowledge of carcinogenesis. Molecular intra-tumour and inter-tumour heterogeneity are also addressed as temporal heterogeneity. Lung cancer heterogeneity has implications in pathogenesis understanding, diagnosis, selection of tissue for molecular diagnosis, as well as therapeutic decision. The understanding of tumour heterogeneity is crucial and we must be aware of the implications and future developments regarding this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496
Epidermal growth factor receptor mutations in lung cancer
Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170
Thatcher, N., Chang, A., Parikh, P., Rodrigues Pereira, J., Ciuleanu, T., von Pawel, J., Thongprasert, S., Tan, E. H., Pemberton, K., Archer, V., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67625-8 · Cited by 2,079
Intra-tumour heterogeneity: a looking glass for cancer?
Marusyk, A., Almendro, V., & Polyak, K. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3261 · Cited by 2,000
Pathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
Thress, K. S., Paweletz, C. P., Felip, E., Cho, B. C., Stetson, D., Dougherty, B., Lai, Z., Markovets, A., Vivancos, A., Kuang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3854 · Cited by 1,589
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Aslakson, C. J., & Miller, F. R. (1992) · PubMed · Cited by 1,234
Gerlinger, M., Horswell, S., Larkin, J., Rowan, A. J., Salm, M. P., Varela, I., Fisher, R., McGranahan, N., Matthews, N., Santos, C. R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2891 · Cited by 1,208
Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
(2014) · Annals of Oncology · doi:10.1093/annonc/mdu312.5 · Cited by 1,169
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Shackleton, M., Quintana, E., Fearon, E. R., & Morrison, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.08.017 · Cited by 1,162
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
Wang, Y., Waters, J., Leung, M. L., Unruh, A., Roh, W., Shi, X., Chen, K., Scheet, P., Vattathil, S., Liang, H., et al. (2014) · Nature · doi:10.1038/nature13600 · Cited by 1,029
Yoshizawa, A., Motoi, N., Riely, G. J., Sima, C. S., Gerald, W. L., Kris, M. G., Park, B. J., Rusch, V. W., & Travis, W. D. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.232 · Cited by 976
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Zhang, J., Fujimoto, J., Zhang, J., Wedge, D. C., Song, X., Zhang, J., Seth, S., Chow, C.-W., Cao, Y., Gumbs, C., et al. (2014) · Science · doi:10.1126/science.1256930 · Cited by 965
Weiss, J., Sos, M. L., Seidel, D., Peifer, M., Zander, T., Heuckmann, J. M., Ullrich, R. T., Menon, R., Maier, S., Soltermann, A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001451 · Cited by 821
Tumor heterogeneity and the biology of cancer invasion and metastasis.
Fidler, I. J. (1978) · PubMed · Cited by 818
Oxnard, G. R., Paweletz, C. P., Kuang, Y., Mach, S. L., O'Connell, A., Messineo, M. M., Luke, J. J., Butaney, M., Kirschmeier, P., Jackman, D. M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2482 · Cited by 786
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Kreso, A., O'Brien, C. A., van Galen, P., Gan, O. I., Notta, F., Brown, A. M. K., Ng, K., Ma, J., Wienholds, E., Dunant, C., et al. (2013) · Science · doi:10.1126/science.1227670 · Cited by 744
Zhu, C.-Q., da Cunha Santos, G., Ding, K., Sakurada, A., Cutz, J.-C., Liu, N., Zhang, T., Marrano, P., Whitehead, M., Squire, J. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8924 · Cited by 661
Russell, P. A., Wainer, Z., Wright, G. M., Daniels, M., Conron, M., & Williams, R. A. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318221f701 · Cited by 624
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K., Yatabe, Y., Powell, C. A., Beer, D., Riely, G., Garg, K., et al. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201107-042st · Cited by 586
Rusch, V. W., Baselga, J. M., Cordon‐Cardo, C., Orazem, J. P., Zaman, M., Hoda, S. A., McIntosh, J., Kurie, J. M., & Dmitrovsky, E. (1993) · PubMed · Cited by 482
Mok, T., Wu, Y.-L., Lee, J. S., Yu, C.-J., Sriuranpong, V., Sandoval-Tan, J., Ladrera, G., Thongprasert, S., Srimuninnimit, V., Liao, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2594 · Cited by 468
Piotrowska, Z., Niederst, M. J., Karlovich, C. A., Wakelee, H. A., Neal, J. W., Mino-Kenudson, M., Fulton, L., Hata, A. N., Lockerman, E. L., Kalsy, A., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0399 · Cited by 458
Douillard, J.-Y., Ostoros, G., Cobo, M., Ciuleanu, T., Cole, R., McWalter, G., Walker, J., Dearden, S., Webster, A., Milenkova, T., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000263 · Cited by 448
Hatt, M., Majdoub, M., Vallières, M., Tixier, F., Le Rest, C. C., Groheux, D., Hindié, E., Martineau, A., Pradier, O., Hustinx, R., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.144055 · Cited by 438
Yoshizawa, A., Sumiyoshi, S., Sonobe, M., Kobayashi, M., Fujimoto, M., Kawakami, F., Tsuruyama, T., Travis, W. D., Date, H., & Haga, H. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182769aa8 · Cited by 436
Cell Plasticity and Heterogeneity in Cancer
Marjanovic, N. D., Weinberg, R. A., & Chaffer, C. L. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.184655 · Cited by 400
Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
Dutt, A., Ramos, A. H., Hammerman, P. S., Mermel, C., Cho, J., Sharifnia, T., Chande, A., Tanaka, K. E., Stransky, N., Greulich, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020351 · Cited by 369
A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer
Calbo, J., van Montfort, E., Proost, N., van Drunen, E., Beverloo, H. B., Meuwissen, R., & Berns, A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.021 · Cited by 369
Cappuzzo, F., Jänne, P. A., Skokan, M., Finocchiaro, G., Rossi, E., Ligorio, C., Zucali, P. A., Terracciano, L., Toschi, L., Roncalli, M., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn635 · Cited by 319
Epidermal growth factor receptor family in lung cancer and premalignancy
Franklin, W. A., Veve, R., Hirsch, F. R., Helfrich, B. A., & Bunn, P. A. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.31520 · Cited by 306
Zhou, W., Gurubhagavatula, S., Liu, G., Park, S., Neuberg, D. S., Wain, J. C., Lynch, T. J., Su, L., & Christiani, D. C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0247 · Cited by 291
ERCC1 Expression Is a Predictor of Survival in Resected Patients With Non-small Cell Lung Cancer
Simon, G. R., Sharma, S., Cantor, A., Smith, P., & Bepler, G. (2005) · Chest · doi:10.1378/chest.127.3.978 · Cited by 277
Meert, A.-P., Martin, B., Delmotte, P., Berghmans, T., Lafitte, J.-J., Mascaux, C., Paesmans, M., Steels, E., Verdebout, J.-M., & Sculier, J.-P. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00296502 · Cited by 264
Schmid, K., Oehl, N., Wrba, F., Pirker, R., Pirker, C., & Filipits, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0089 · Cited by 262
Taniguchi, K., Okami, J., Kodama, K., Higashiyama, M., & Kato, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00782.x · Cited by 256
Ware, K. E., Hinz, T. K., Kleczko, E., Singleton, K. R., Marek, L. A., Helfrich, B. A., Cummings, C. T., Graham, D. K., Astling, D., Tan, A.-C., et al. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.4 · Cited by 249
EGFR Mutation Is Specific for Terminal Respiratory Unit Type Adenocarcinoma
Yatabe, Y., Kosaka, T., Takahashi, T., & Mitsudomi, T. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000157935.28066.35 · Cited by 237
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine
Carrola, J., Rocha, C. M., Barros, A. S., Gil, A. M., Goodfellow, B. J., Carreira, I. M., Bernardo, J., Gomes, A., Sousa, V., Carvalho, L., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr100899x · Cited by 226
Self-citationHeterogeneous Distribution of EGFR Mutations Is Extremely Rare in Lung Adenocarcinoma
Yatabe, Y., Matsuo, K., & Mitsudomi, T. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3906 · Cited by 222
Lineage-Specific Dependency of Lung Adenocarcinomas on the Lung Development Regulator TTF-1
Tanaka, H., Yanagisawa, K., Shinjo, K., Taguchi, A., Maeno, K., Tomida, S., Shimada, Y., Osada, H., Kosaka, T., Matsubara, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4774 · Cited by 216
Gow, C.-H., Chang, Y.-L., Hsu, Y.-C., Tsai, M.-F., Wu, C.-T., Yu, C.-J., Yang, C.-H., Lee, Y.-C., Yang, P.-C., & Shih, J.-Y. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn679 · Cited by 213
Hirsch, F. R., Scagliotti, G. V., Langer, C. J., Varella-Garcia, M., & Franklin, W. A. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00137-5 · Cited by 208
Kalikaki, A., Koutsopoulos, A., Trypaki, M., Souglakos, J., Stathopoulos, E., Georgoulias, V, Mavroudis, D., & Voutsina, A. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604629 · Cited by 206
Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study
Giaccone, G., Gallegos Ruiz, M., Le Chevalier, T., Thatcher, N., Smit, E., Rodriguez, J. A., Janne, P., Oulid-Aissa, D., & Soria, J.-C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0260 · Cited by 201
Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non–Small-Cell Lung Cancer
Bai, H., Wang, Z., Chen, K., Zhao, J., Lee, J. J., Wang, S., Zhou, Q., Zhuo, M., Mao, L., An, T., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.3744 · Cited by 199
Sorensen, B. S., Wu, L., Wei, W., Tsai, J., Weber, B., Nexo, E., & Meldgaard, P. (2014) · Cancer · doi:10.1002/cncr.28964 · Cited by 194
Marchetti, A., Palma, J. F., Felicioni, L., De Pas, T. M., Chiari, R., Del Grammastro, M., Filice, G., Ludovini, V., Brandes, A., Chella, A., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000643 · Cited by 182
Frequent EGFR mutations in brain metastases of lung adenocarcinoma
Matsumoto, S., Takahashi, K., Iwakawa, R., Matsuno, Y., Nakanishi, Y., Kohno, T., Shimizu, E., & Yokota, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.21940 · Cited by 181
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K., Yatabe, Y., Ishikawa, Y., Wistuba, I., Flieder, D. B., Franklin, W., et al. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0264-ra · Cited by 179
DNA repair and cisplatin resistance in non-small-cell lung cancer
Rosell, R., Lord, R. V. N., Taron, M., & Reguart, N. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00224-6 · Cited by 178
Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the Lung
Pelosi, G., Fraggetta, F., Pasini, F., Maisonneuve, P., Sonzogni, A., Iannucci, A., Terzi, A., Bresaola, E., Valduga, F., Lupo, C., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200103000-00011 · Cited by 175
Chen, Z.-Y., Zhong, W.-Z., Zhang, X.-C., Su, J., Yang, X.-N., Chen, Z.-H., Yang, J.-J., Zhou, Q., Yan, H.-H., An, S.-J., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0385 · Cited by 165
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma
Rocha, C. M., Carrola, J., Barros, A. S., Gil, A. M., Goodfellow, B. J., Carreira, I. M., Bernardo, J., Gomes, A., Sousa, V., Carvalho, L., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200550p · Cited by 164
Self-citationSun, P.-L., Seol, H., Lee, H. J., Yoo, S. B., Kim, H., Xu, X., Jheon, S., Lee, C.-T., Lee, J.-S., & Chung, J.-H. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182381515 · Cited by 163
Weber, B., Meldgaard, P., Hager, H., Wu, L., Wei, W., Tsai, J., Khalil, A. A., Nexø, E., & Sørensen, B. S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-294 · Cited by 162
Targeting the epidermal growth factor receptor in non-small cell lung cancer.
Herbst, R. S., & Bunn, P. A. (2003) · PubMed · Cited by 162
Rocha, C., Barros, A. S., Gil, A. M., Goodfellow, B. J., Humpfer, E., Spraul, M., Carreira, I. M., Melo, J. B., Bernardo, J., Gomes, A., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr9006574 · Cited by 160
Self-citationPark, S. E., Tisch, A. H., Cho, E. Y., Shim, Y. M., Kim, J., Kim, H. S., Lee, J., Park, Y. H., Ahn, J. S., Park, K., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a94af4 · Cited by 156
Nucleotide Excision Repair Pathways Involved in Cisplatin Resistance in Non-Small-Cell Lung Cancer
Rosell, R., Tarón, M., Barnadas, A., et al. (2003) · Cancer Control · doi:10.1177/107327480301000404 · Cited by 156
van Zandwijk, N., Mathy, A., Boerrigter, L., Ruijter, H. J., Tielen, I. H. G., de Jong, D., Baas, P., Burgers, S. A., & Nederlof, P. M. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl323 · Cited by 156
Tan, D., Li, Q., Deeb, G., Ramnath, N., Slocum, H. K., Brooks, J. S., Cheney, R., Wiseman, S. M., Anderson, T., & Loewen, G. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00180-1 · Cited by 152
Chemoresistance in Non-Small Cell Lung Cancer
Sève, P., & Dumontet, C. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011053352604 · Cited by 149
Thyroid transcription factor 1—a new prognostic factor in lung cancer: a meta-analysis
Berghmans, T., Paesmans, M., Mascaux, C., Martin, B., Meert, A.-P., Haller, A., Lafitte, J., & Sculier, J. P. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl287 · Cited by 138
c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung
Li, Z. H. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)96453-3 · Cited by 127
Han, H., Eom, D., Kim, J. H., Kim, K., Shin, H.-M., An, J. Y., Lee, K. M., Choe, K. H., Lee, K. H., Kim, S. T., et al. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.02.006 · Cited by 120
Circulating Cell-Free Tumour DNA in the Management of Cancer
Francis, G. D., & Stein, S. R. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160614122 · Cited by 117
Berger, W., Setinek, U., Mohr, T. T., Kindås-Mügge, I., Vetterlein, M., Dekan, G., Eckersberger, F., Caldas, C. H., & Micksche, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991029)83:3<415::aid-ijc19>3.0.co;2-y · Cited by 115
EGFR mutations and the terminal respiratory unit
Yatabe, Y. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9205-8 · Cited by 115
Behrens, C., Lin, H. Y., Lee, J. J., Raso, M. G., Hong, W. K., Wistuba, I. I., & Lotan, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0167 · Cited by 108
Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium.
Kurie, J. M., Shin, H. J. C., Lee, J. S., Morice, R., Ro, J. Y., Lippman, S. M., Hittelman, W. N., Ren, Y. T., Lee, J. J., & Hong, W. K. (1996) · PubMed · Cited by 107
Chen, H.-J., Mok, T. S. K., Chen, Z. H., Guo, A., Zhang, X., Su, J., & Wu, Y.-L. L. C. (2009) · Pathology & Oncology Research · doi:10.1007/s12253-009-9167-8 · Cited by 107
Adenosquamous Carcinoma of the Lung
Tochigi, N., Đačić, S., Nikiforova, M. N., Cieply, K. M., & Yousem, S. A. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp08iqzaogylfl · Cited by 104
Piyathilake, C. J., Frost, A. R., Manne, U., Weiss, H. L., Bell, W. C., Heimburger, D. C., & Grizzle, W. E. (2002) · PubMed · Cited by 103
Rocha, C., Barros, A. S., Goodfellow, B. J., Carreira, I. M., Gomes, A., de Sousa, V. M. L., Bernardo, J., Carvalho, L., Gil, A. M., & Duarte, I. F. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu226 · Cited by 100
Self-citationEvidence for the epidermal growth factor receptor as a target for lung cancer prevention.
Lonardo, F., Dragnev, K. H., Freemantle, S. J., Ma, Y., Memoli, N., Sekula, D., Knauth, E. A., BEEBE, J. S., & Dmitrovsky, E. (2002) · PubMed · Cited by 98
Pathology, T. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)96325-p · Cited by 97
Bai, H., Wang, Z., Wang, Y., Zhuo, M., Zhou, Q., Duan, J., Yang, L., Wu, M., An, T., Zhao, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054170 · Cited by 96
Jung, H. S., Park, D. K., Kim, M. J., Yu, S. K., Kwon, K. A., Ku, Y. S., Kim, Y. K., & Kim, J. H. (2009) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2009.24.1.43 · Cited by 93
Sun, L., Zhang, Q., Luan, H., Zhan, Z., Wang, C., & Sun, B. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-30 · Cited by 92
Bose, D., Zimmerman, L. J., Pierobon, M., Petricoin, E. F., Tozzi, F., Parikh, A., Fan, F., Dallas, N. A., Xia, L., Gaur, P., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.449 · Cited by 87
Chen, H., & Cheng, X. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s66502 · Cited by 86
Perner, S., Wagner, P., Soltermann, A., Lafargue, C. J., Tischler, V., Weir, B. A., Weder, W., Meyerson, M. M., Giordano, T. J., Moch, H., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2443 · Cited by 81
Volm, M., Koomägi, R., Mattern, J., & Stammler, G. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00411-x · Cited by 80
A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases
Monaco, S. E., Nikiforova, M. N., Cieply, K. M., Teot, L. A., Khalbuss, W. E., & Đačić, S. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.019 · Cited by 79
Bordi, P., Re, M. D., Danesi, R., & Tiseo, M. (2015) · PubMed · doi:10.3978/j.issn.2218-6751.2015.08.09 · Cited by 78
Song, Z., Zhu, H., Guo, Z., Wu, W., Sun, W., & Zhang, Y. (2013) · Medical Oncology · doi:10.1007/s12032-013-0645-1 · Cited by 76
Nakamura, T., Sueoka‐Aragane, N., Iwanaga, K., Sato, A., Komiya, K., Abe, T., Ureshino, N., Hayashi, S., Hosomi, T., Hirai, M., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31822956e8 · Cited by 76
Dønnem, T., Al-Shibli, K. I., Al‐Saad, S., Busund, L., & Bremnes, R. M. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31819f2e38 · Cited by 75
Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors.
Miller, B. E., Miller, F. R., Wilburn, D., & Heppner, G. H. (1988) · PubMed · Cited by 72
Giatromanolaki, A. N., Koukourakis, M. I., O'Byrne, K. J., Kaklamanis, L., Dicoglou, C., Trichia, E., Whitehouse, R. M., Harris, A. L., & Gatter, K. C. (1996) · PubMed · Cited by 70
Neelakantan, D., Drasin, D. J., & Ford, H. L. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.972761 · Cited by 69
Sherwood, J. L., Dearden, S. P., Ratcliffe, M., & Walker, J. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0207-9 · Cited by 65
KRAS mutation status in primary nonsmall cell lung cancer and matched metastases
Cortot, A. B., Italiano, A., Burel‐Vandenbos, F., Martel‐Planche, G., & Hainaut, P. L. (2010) · Cancer · doi:10.1002/cncr.25014 · Cited by 64
MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)
Casadevall, D., Gimeno, J., Clavé, S., Taus, Á., Pijuán, L., Arumí, M., Lorenzo, M., Menéndez, S., Cañadas, I., Albanell, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3976 · Cited by 64
Badalian, G., Barbai, T., Rásó, E., Derecskei, K., Szendröi, M., & Tı́már, J. (2007) · Pathology & Oncology Research · doi:10.1007/bf02893484 · Cited by 58
Renovanz, M., & Kim, E. L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00142 · Cited by 57
Cancer Cell Phenotypes, in Fifty Shades of Grey
Marusyk, A., & Polyák, K. (2013) · Science · doi:10.1126/science.1234415 · Cited by 57
Luo, D., Ye, X., Hu, Z. M., Peng, K., Song, Y., Yin, X., Zhu, G., Ji, Q., & Peng, Y.-P. (2013) · Tumor Biology · doi:10.1007/s13277-013-1323-9 · Cited by 54
Predictive biomarkers in precision medicine and drug development against lung cancer
Fang, B., Mehran, R. J., Heymach, J. V., & Swisher, S. G. (2015) · 癌症:英文版 · doi:10.1186/s40880-015-0028-4 · Cited by 52
Kim, D., Jung, J., Son, S. H., Kim, C.-Y., Hong, C. M., Oh, J.-R., Jeong, S. Y., Lee, S., Lee, J., & Ahn, B. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000867 · Cited by 52
Duarte, I. F., Rocha, C., Barros, A. S., Gil, A. M., Goodfellow, B. J., Carreira, I. M., Bernardo, J., Gomes, A., de Sousa, V. M. L., & Carvalho, L. (2010) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-010-0993-6 · Cited by 42
Self-citationAnalysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma
Tomonaga, N., Nakamura, Y., Yamaguchi, H., Ikeda, T., Mizoguchi, K., Motoshima, K., Doi, S., Nakatomi, K., Iida, T., Hayashi, T., et al. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.04.005 · Cited by 37
Marino, F. Z., Liguori, G., Aquino, G., Mantia, E. L., Bòsari, S., Ferrero, S., Rosso, L., Gaudioso, G., Rosa, N. D., Scrima, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139264 · Cited by 37
Metz, S., Ganter, C., Lorenzen, S., van Marwick, S., Holzapfel, K., Herrmann, K., Rummeny, E. J., Wester, H., Schwaiger, M., Nekolla, S. G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132386 · Cited by 36
K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma
Li, S., Rosell, R., Urban, A., Pous, A. F., Ariza, A., Armengol, M. P., Abad, A., Navas-Palacios, J., & Monzó, M. (1994) · Lung Cancer · doi:10.1016/0169-5002(94)90279-8 · Cited by 36
Sumiyoshi, S., Yoshizawa, A., Sonobe, M., Kobayashi, M., Sato, M., Fujimoto, M., Tsuruyama, T., Date, H., & Haga, H. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.03.013 · Cited by 34
Kim, S. T., Sung, J. S., Jo, U., Park, K. H., Shin, S. W., & Kim, Y. H. (2013) · Medical Oncology · doi:10.1007/s12032-012-0328-3 · Cited by 33
Remón, J., & Majem, M. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2013.10.14 · Cited by 31
Kim, E. Y., Cho, E. N., Park, H. S., Kim, A., Hong, J. Y., Lim, S., Youn, J. P., Hwang, S. Y., & Chang, Y. S. (2016) · BMC Cancer · doi:10.1186/s12885-016-2049-z · Cited by 31
Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer
Alsdorf, W. H., Clauditz, T. S., Hoenig, T., Quaas, A., Sirma, H., Koenig, A. M., Izbicki, J. R., Sauter, G., Marx, A. H., & Grob, T. J. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.09.016 · Cited by 27
Mansuet‐Lupo, A., Zouiti, F., Alifano, M., Tallet, A., Charpentier, M.-C., Ducruit, V., Devez, F., Lemaitre, F., Laurent‐Puig, P., Damotte, D., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-131 · Cited by 25
Hormone-sensitive prostate cancer: a case of ETS gene fusion heterogeneity
Attard, G., Jameson, C., Moreira, J. P. T., Flohr, P., Parker, C. C., Dearnaley, D. P., Cooper, C. S., & Bono, J. S. D. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.061515 · Cited by 24
Kim, H. K., Lee, H. Y., Choi, Y., Choi, S., Choi, H., Lee, J., Han, J., Ahn, M., Lee, K. S., & Kim, J. (2014) · PubMed · Cited by 21
Consistent mutation status within histologically heterogeneous lung cancer lesions
Mattsson, J. S. M., Imgenberg‐Kreuz, J., Edlund, K., Botling, J., & Micke, P. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04245.x · Cited by 21
Wright, G. M., Do, H., Weiss, J. M., Alam, N. Z., Rathi, V., Walkiewicz, M., John, T., Russell, P. A., & Dobrovic, A. (2014) · Oncotarget · doi:10.18632/oncotarget.1840 · Cited by 21
Munfus-McCray, D., Cui, M., Zhang, Z., Gabrielson, E., Askin, F. B., & Li, Q. K. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.10.016 · Cited by 21
Marcq, M., Vallée, A., Bizieux, A., & Denis, M. G. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000134 · Cited by 20
Intratumoral heterogeneity and consequences for targeted therapies
Turtoï, A., Blomme, A., & Castronovo, V. (2015) · Bulletin du Cancer · doi:10.1016/j.bulcan.2014.12.006 · Cited by 20
Wu, J., Yu, C., Shih, J., Yang, C.-H., & Yang, P. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.04.018 · Cited by 20
de Sousa, V. M. L., Reis, D. F. N., Silva, M. M. P., Alarcão, A., Ladeirinha, A. F., d’Aguiar, M. J., Ferreira, M. T., Balseiro, S., & Carvalho, L. (2016) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-016-1954-5 · Cited by 20
Self-citationThe Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer
Huang, W.-L., Wei, F., Wong, D. T., Lin, C., & Su, W. (2015) · BioMed Research International · doi:10.1155/2015/340732 · Cited by 14
Influence of chemotherapy on EGFR mutation status.
Luo, Y., & Chen, Y. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2013.10.12 · Cited by 13
Zhong, W., Su, J., Xu, F., Zhai, H.-R., Zhang, X., Yang, X., Chen, Z., Chen, Z., Li, W., Dong, S., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.09.007 · Cited by 8
Bronchial-pulmonary adenocarcinoma subtyping relates with different molecular pathways
de Sousa, V. M. L., Lopes-Bastos, B., Silva, M. M. P., Alarcão, A., & Carvalho, L. (2015) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2014.05.006 · Cited by 7
Self-citationZhong, W., Wu, Y.-L. L. C., Yang, X.-N., Guo, A., Su, J., Zhang, X., Luo, D., Wang, Z., Chen, H.-J., Zhou, Q. H., et al. (2010) · Clinical Lung Cancer · doi:10.3816/clc.2010.n.020 · Cited by 7
Tumor Heterogeneity-Based Resistance Guides Personalized Cancer Medicine
Lianos, G. D., Mangano, A., Rausei, S., Katsios, C. G., & Roukos, D. H. (2014) · Future Oncology · doi:10.2217/fon.14.122 · Cited by 5
de Sousa, V. M. L., Rodrigues, C., Silva, M. M. P., Alarcão, A., & Carvalho, L. (2015) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2014.09.009 · Cited by 5
Self-citation
Cited by
Mitochondrial CPT1A: Insights into structure, function, and basis for drug development
Liang, K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1160440 · Cited by 156
Metadata
- Authors
- de Sousa, V. M. L., & Carvalho, L.
- Venue
- Pathobiology
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 85
- Issue
- 1-2
- Pages
- 96-107
- ISSN
- 1015-2008 (ISSN-L)
- 1423-0291
- OpenAlex
- W2796573946
- Cited by
- 364
- References
- 130
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.